Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease

被引：0
|
作者：
Lee, Kelvin H. [1 ]
Relkin, Norman R. [1 ]
机构：
[1] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
来源：
ANNALS OF NEUROLOGY | 2007年 / 61卷 / 05期
关键词：
D O I：
10.1002/ana.21126
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：497 / 498
页数：2
相关论文
共 50 条
  • [41] Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer's Disease
    Higginbotham, Lenora
    Ping, Lingyan
    Dammer, Eric
    Duong, Duc
    Zhou, Maotian
    Gearing, Marla
    Johnson, Erik
    Hajjar, Ihab
    Lah, James
    Levey, Allan
    Seyfried, Nicholas
    NEUROLOGY, 2020, 94 (15)
  • [42] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Blennow, Kaj
    Hampel, Harald
    Weiner, Michael
    Zetterberg, Henrik
    NATURE REVIEWS NEUROLOGY, 2010, 6 (03) : 131 - 144
  • [43] Cerebrospinal fluid biomarkers in the evaluation of Alzheimer disease
    Verbeek, Marcel M.
    Rikkert, Marcel G. M. Olde
    CLINICAL CHEMISTRY, 2008, 54 (10) : 1589 - 1591
  • [44] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Kaj Blennow
    Harald Hampel
    Michael Weiner
    Henrik Zetterberg
    Nature Reviews Neurology, 2010, 6 : 131 - 144
  • [45] Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
    Irwin, David J.
    Fedler, Janel
    Coffey, Christopher S.
    Caspell-Garcia, Chelsea
    Kang, Ju Hee
    Simuni, Tanya
    Foroud, Tatiana
    Toga, Arthur W.
    Tanner, Caroline M.
    Kieburtz, Karl
    Chahine, Lana M.
    Reimer, Alyssa
    Hutten, Samantha
    Weintraub, Daniel
    Mollenhauer, Brit
    Galasko, Douglas R.
    Siderowf, Andrew
    Marek, Kenneth
    Trojanowski, John Q.
    Shaw, Leslie M.
    ANNALS OF NEUROLOGY, 2020, 88 (03) : 574 - 587
  • [46] Cerebrospinal fluid biomarkers in Alzheimer's disease, Parkinson's disease and atypical parkinsonism
    Stojmenovic, G. Mandic
    Markovic, I.
    Stojkovic, T.
    Despotovic, I.
    Lukic, M. Jecmenica
    Stefanova, E.
    Kostic, V.
    MOVEMENT DISORDERS, 2012, 27 : S386 - S386
  • [47] Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
    Portelius, Erik
    Brinkmalm, Gunnar
    Pannee, Josef
    Zetterberg, Henrik
    Blennow, Kaj
    Dahlen, Rahil
    Brinkmalm, Ann
    Gobom, Johan
    EXPERT REVIEW OF PROTEOMICS, 2017, 14 (11) : 1007 - 1020
  • [48] Standardized multiparameter quantification of biomarkers for Alzheimer's disease in cerebrospinal fluid
    Vanderstichele, H
    Demeyer, L
    De Roo, K
    Van Remoortere, S
    Mortier, V
    Olsson, A
    Vandecasteele, L
    Kostanjevecki, V
    Blennow, K
    Vanmechelen, E
    New Trends in Alzheimer and Parkinson Related Disorders: ADPD 2005, 2005, : 183 - 189
  • [49] Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
    Schindler, Suzanne E.
    Li, Yan
    Todd, Kaitlin W.
    Herries, Elizabeth M.
    Henson, Rachel L.
    Gray, Julia D.
    Wang, Guoqiao
    Graham, Danielle L.
    Shaw, Leslie M.
    Trojanowski, John Q.
    Hassenstab, Jason J.
    Benzinger, Tammie L. S.
    Cruchaga, Carlos
    Jucker, Mathias
    Levin, Johannes
    Chhatwal, Jasmeer P.
    Noble, James M.
    Ringman, John M.
    Graff-Radford, Neill R.
    Holtzman, David M.
    Ladenson, Jack H.
    Morris, John C.
    Bateman, Randall J.
    Xiong, Chengjie
    Fagan, Anne M.
    ALZHEIMERS & DEMENTIA, 2019, 15 (05) : 655 - 665
  • [50] Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1199 - 1209
12345